Pamela Blair Allen

11PUBLICATIONS
85CO-AUTHORS
Predictive and prognostic markersMolecular targetsDental materials and equipmentCancer therapy (excl. chemotherapy and radiation therapy)Social epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 19, 2024
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.

Francine M Foss, Youn H Kim, H Miles Prince

|May 13, 2024
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.

Rahul S Bhansali, Fredrik Ellin, Thomas Relander

|Mar 18, 2024
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.

Megan Melody, Narendranath Epperla, Geoffrey Shouse

|Oct 25, 2023
Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.

Joshua D Preston, Caroline S Jansen, Siddhartha Kosaraju

Pageof 2